Expression of TNFRSF6B in kidneys is a novel predictor for progression of chronic kidney disease

Modern Pathology

Volumn 26, Issue 7, 2013, Pages 984-994

  Tseng, Wei Cheng ^a   Yang, Wu Chang ^b   Yang, An Hang ^b   Hsieh, Shie Liang ^b,c   Tarng, Der Cherng ^b,c  

^a TAIPEI CITY HOSPITAL   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

chronic kidney disease; kidney disease progression; renal fibrogenesis; TNFRSF6B

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSIN RECEPTOR ANTAGONIST; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DECOY RECEPTOR 3; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MYCOPHENOLIC ACID; PROTEIN; BIOLOGICAL MARKER; TNFRSF6B PROTEIN, HUMAN;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD SAMPLING; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COMPUTER ASSISTED DIAGNOSIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY INTERSTITIUM; KIDNEY PARENCHYMA; KIDNEY TUBULE EPITHELIUM; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; PROTEINURIA; RENAL REPLACEMENT THERAPY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; TERTIARY HEALTH CARE; URINARY EXCRETION; BIOSYNTHESIS; CHRONIC KIDNEY FAILURE; DISEASE COURSE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS;

BIOLOGICAL MARKERS; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 6B; RENAL INSUFFICIENCY, CHRONIC;

EID: 84879939157     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2013.29     Document Type: Article

References (25)

1. James MT, Hemmelgarn BR, Tonelli M. Early recognition and prevention of chronic kidney disease. Lancet 2010;375:1296-1309.
2. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351: 1296-1305.
3. de Zeeuw D, Hillege HL, de Jong PE. The kidney, a cardiovascular risk marker, and a new target for therapy. Kidney Int Suppl 2005;98:S25-S29.
4. Wen CP, Cheng TY, Tsai MK, et al. All-cause mortality attributable to chronic kidney disease: A prospective cohort study based on 462 293 adults in Taiwan. Lancet 2008;371:2173-2182. (Pubitemid 351890412)
5. Kent DM, Jafar TH, Hayward RA, et al. Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease. J Am Soc Nephrol 2007;18: 1959-1965.
6. Taal MW, Brenner BM. Renal risk scores: Progress and prospects. Kidney Int 2008;73:1216-1219. (Pubitemid 351693152)
7. Levey AS, Cattran D, Friedman A, et al. Proteinuria as a surrogate outcome in CKD: Report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. Am J Kidney Dis 2009;54:205-226.
8. Pitti RM, Marsters SA, Lawrence DA, et al. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature 1998;396:699-703. (Pubitemid 29003951)
9. Yu KY, Kwon B, Ni J, et al. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J Biol Chem 1999;274:13733-13736.
10. Migone TS, Zhang J, Luo X, et al. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 2002;16:479-492. (Pubitemid 34260924)
11. Lin WW, Hsieh SL. Decoy receptor 3: A pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer. Biochem Pharmacol 2011;81:838-847.
12. Chen J, Zhang L, Kim S. Quantification and detection of DcR3, a decoy receptor in TNFR family. J Immunol Methods 2004;285:63-70. (Pubitemid 38186586)
13. Hung SC, Hsu TW, Lin YP, et al. Decoy receptor 3, a novel inflammatory marker, and mortality in hemodialysis patients. Clin J Am Soc Nephrol 2012;7: 1257-1265.
14. Bai C, Connolly B, Metzker ML, et al. Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster. Proc Natl Acad Sci USA 2000; 97:1230-1235. (Pubitemid 30080841)
15. Risdon RA, Sloper JC, De Wardener HE. Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis. Lancet 1968;2: 363-366.
16. Zeisberg M, Neilson EG. Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol 2010;21:1819-1834.
17. Strutz F, Zeisberg M. Renal fibroblasts and myofibroblasts in chronic kidney disease. J Am Soc Nephrol 2006;17:2992-2998. (Pubitemid 44707759)
18. Hayashi S, Miura Y, Nishiyama T, et al. Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis. Arthritis Rheum 2007;56:1067-1075. (Pubitemid 46608631)
19. Cheng L, Chen Y. Anti-Fas antibody induces apoptosis in cultured human renal interstitial fibroblasts. Chin Med J (Engl) 2001;114:162-166. (Pubitemid 33611113)
20. Lin SL, Chen RH, Chen YM, et al. Pentoxifylline attenuates tubulointerstitial fibrosis by blocking Smad3/4-activated transcription and profibrogenic effects of connective tissue growth factor. J Am Soc Nephrol 2005;16:2702-2713.
21. Lee PY, Chien Y, Chiou GY, et al. Induced pluripotent stem cells without c-Myc attenuate acute kidney injury via down-regulating the signaling of oxidative stress and inflammation in ischemia- reperfusion rats. Cell Transplant 2012;21:2569-2585.
22. Hsu YH, Lin WL, Hou YT, et al. Podocalyxin EBP50 ezrin molecular complex enhances the metastatic potential of renal cell carcinoma through recruiting Rac1 guanine nucleotide exchange factor ARHGEF7. Am J Pathol 2010;176:3050-3061.
23. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006;145: 247-254. (Pubitemid 46768608)
24. Pencina MJ, D'Agostino RB. Overall C as a measure of discrimination in survival analysis: Nodel specific population value and confidence interval estimation. Stat Med 2004;23:2109-2123. (Pubitemid 38968032)
25. Rule AD, Elsherbiny H. Chronic kidney disease: Endogenous filtration markers-is it time to move beyond eGFR? Nat Rev Nephrol 2012;8:10-12.